Navigation Links
Vermillion Announces Appointment of John Hamilton to Board of Directors
Date:4/10/2008

FREMONT, Calif., April 10 /PRNewswire-FirstCall/ -- Vermillion, Inc. (Nasdaq: VRML), a molecular diagnostics company, today announced the appointment of John F. Hamilton to its board of directors. Mr. Hamilton is the former vice president and chief financial officer of Depomed, Inc., a specialty pharmaceutical company.

"John brings more than 20 years of active board-level engagement on financial, strategic and audit matters to Vermillion. His solid experience working with small to mid-size companies in the healthcare sector is a perfect fit with our business model," said Gail Page, President and CEO of Vermillion. "We are pleased to welcome John to the board, especially at such an exciting time in the company's evolution as we prepare to commercialize several of our diagnostic tests later this year. His financial savvy and analytical approach will prove invaluable to the Company."

Mr. Hamilton began his career in the banking industry and went on to hold senior financial positions at several biopharmaceutical companies including Glyko, Inc. -- now BioMarin Pharmaceuticals -- and Chiron Corporation. He sits on the regional board of directors of the Association of Bioscience Financial Officers and is past-president of the Treasurers Club of San Francisco. Mr. Hamilton received his M.B.A. from the University of Chicago and his B.A. in International Relations from the University of Pennsylvania.

Mr. Hamilton's appointment to Vermillion's board of directors went into effect on April 9, 2008. Additionally, Mr. Hamilton will serve as chairman of the Company's audit committee. He will replace Judy Bruner, executive vice president of administration and chief financial officer of SanDisk Corporation, who resigned from the board
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Vermillion Biomarker Panel Potential Aid in the Diagnosis of Peripheral Artery Disease
2. Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization
3. Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones
4. Vermillion Announces Effectiveness of Reverse Stock Split
5. Vermillion and Stanford University Sign Exclusive License Agreement for Novel Biomarker Panel to Assess Peripheral Artery Disease Risk
6. Vermillion Receives NASDAQ Notice of Non-Compliance
7. Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests
8. Vermillion to Webcast Presentation at the Acumen BioFin 9th Annual Healthcare Conference, November 5-7, New York
9. Vermillion, Inc. Announces Receipt Of Notice Of Compliance From Nasdaq
10. Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease
11. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... 2013 The Stirling Ultracold Model ... Inc., Athens, OH, USA, won the Outstanding New Product ... Society for Biological and Environmental Repositories (ISBER) at their ... one product annually, recognizes the company’s development and introduction ... The award was presented to Global Cooling’s CEO ...
(Date:5/16/2013)... Cambridge Healthtech Institute will host its ... at the Renaissance Waterfront Hotel in Boston, MA. ... look at the current strategies and innovations for optimizing ... Leaders in the field will reveal how their work ... greater specificity and efficiency. , “In this age of ...
(Date:5/16/2013)... As the weather warms, women everywhere are waiting for ... most make a statement with fashion, many change their makeup ... weather mixes makeup and sweat to produce, and increase acne ... during warmer months, Adult Acne treatment , Probiotic Action ... ways to deter breakouts. , Recently, an article from ...
(Date:5/16/2013)... (PRWEB) May 16, 2013 DNA Genotek, a ... ‘Spit for Africa’, a sponsorship program in conjunction with the ... designed to improve access and reduce the cost of ... such as the Human Heredity and Health in Africa (H3 ... AfSHG. , The aim of the AfSHG is ...
Breaking Biology Technology:Stirling Ultracold Ultra-Low Freezer Wins 2013 Outstanding New Product Award at International Biorepository Conference, Sydney, Australia 2The 2013 Bioprocessing Summit to Bring Together International Leaders to Discuss Today's Bioprocess Issues From Cell Line Selection to Manufacturing in Boston, MA 2Adult Acne Treatment, Probiotic Action Shares New Tips for Women on How to Fight Acne While Wearing Makeup 2DNA Genotek Inc. Announces Spit for Africa Program 2DNA Genotek Inc. Announces Spit for Africa Program 3
... Inc. (NYSE Amex: NBS ) ("NeoStem" or ... the U.S. and China, appeared on Thursday at the ... announcement of the signing of a definitive merger agreement ... The definitive merger agreement provides for the issuance ...
... (NYSE Amex: PTN ) today announced the ... strategic reassessment of its research and development activities and ... and efforts on clinical trials of bremelanotide for male ... asthma. In implementing this plan, Palatin is reducing its ...
... -- TCT 2010, WASHINGTON, September 24, 2010 ... ... ... Results are keyed by longUrl, so we need to grab the first one. for (var r in ...
Cached Biology Technology:NeoStem Presented at NASDAQ MarketSite in New York to Discuss Entry Into Merger Agreement With Progenitor Cell Therapy 2NeoStem Presented at NASDAQ MarketSite in New York to Discuss Entry Into Merger Agreement With Progenitor Cell Therapy 3Palatin Announces Strategic Realignment of Operations 2Palatin Announces Strategic Realignment of Operations 3Palatin Announces Strategic Realignment of Operations 4Palatin Announces Strategic Realignment of Operations 5Inspire MD Announce the MASTER (MGUARD for Acute ST Elevation Reperfusion) Randomized Trial in TCT2010. Study Chairman Will be Dr. Gregg Stone 2Inspire MD Announce the MASTER (MGUARD for Acute ST Elevation Reperfusion) Randomized Trial in TCT2010. Study Chairman Will be Dr. Gregg Stone 3Inspire MD Announce the MASTER (MGUARD for Acute ST Elevation Reperfusion) Randomized Trial in TCT2010. Study Chairman Will be Dr. Gregg Stone 4Inspire MD Announce the MASTER (MGUARD for Acute ST Elevation Reperfusion) Randomized Trial in TCT2010. Study Chairman Will be Dr. Gregg Stone 5Inspire MD Announce the MASTER (MGUARD for Acute ST Elevation Reperfusion) Randomized Trial in TCT2010. Study Chairman Will be Dr. Gregg Stone 6Inspire MD Announce the MASTER (MGUARD for Acute ST Elevation Reperfusion) Randomized Trial in TCT2010. Study Chairman Will be Dr. Gregg Stone 7
(Date:5/16/2013)... used ancient shorelines to predict the stability of today,s largest ... shoreline from three million years ago, for example when ... to be evidence of a high sea level due to ... many scientists to think that if the world,s largest ice ... the same in our modern, progressively warming world. , ...
(Date:5/16/2013)... Injectable nanoparticles developed at MIT may someday eliminate ... to constantly monitor their blood-sugar levels and inject ... to sense glucose levels in the body and ... thereby replacing the function of pancreatic islet cells, ... diabetes. Ultimately, this type of system could ensure ...
(Date:5/16/2013)... 16, 2013 The relationship between the heritable ... not been clear. Schizophrenia is commonly associated with ... are clues that reduced IQ may be linked ... reduced cognitive ability may precede the onset of ... in healthy relatives of people diagnosed with schizophrenia. ...
Breaking Biology News(10 mins):World's biggest ice sheets likely more stable than previously believed 2Nanotechnology could help fight diabetes 2Nanotechnology could help fight diabetes 3Genetic risk for schizophrenia is connected to reduced IQ 2
... (MRSA) in swine and swine workers in the United States ... The investigators found a strain of MRSA, known as ST398, ... the paper published online Jan. 23 by the science journal ... of swine by MRSA was very common in one of ...
... 22, 2009 -- The Damon Runyon Cancer Research Foundation announced ... cancer have won the 2009 Damon Runyon-Rachleff Innovation Awards. ... year to three projects by early-career scientists that have the ... and treatment of cancer. The 2009 ...
... University] Brown University researchers have identified a cellular ... The finding by Stephen Helfand and Nicola Neretti ... Helfand, a professor of biology, molecular biology, cell biology ... identified a mutation in the Indy ("I,m Not Dead ...
Cached Biology News:Study finds MRSA in Midwestern swine, workers 22009 Damon Runyon-Rachleff Innovation Awards granted for pioneering ideas in cancer research 22009 Damon Runyon-Rachleff Innovation Awards granted for pioneering ideas in cancer research 32009 Damon Runyon-Rachleff Innovation Awards granted for pioneering ideas in cancer research 4Scientists unlock possible aging secret in genetically altered fruit fly 2